Expand raw payload
{
"awards": [
{
"id": "016885-2026-1",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-175395",
"name": "HCA International Limited"
}
]
}
],
"bids": {
"statistics": [
{
"id": "3",
"measure": "bids",
"relatedLot": "1",
"value": 1
},
{
"currency": "GBP",
"id": "1",
"measure": "lowestValidBidValue",
"relatedLot": "1",
"value": 60000.0
},
{
"currency": "GBP",
"id": "2",
"measure": "highestValidBidValue",
"relatedLot": "1",
"value": 60000.0
}
]
},
"buyer": {
"id": "GB-FTS-172659",
"name": "Integrated Laboratory Solutions LLP"
},
"contracts": [
{
"awardID": "016885-2026-1",
"dateSigned": "2026-02-11T00:00:00Z",
"id": "016885-2026-1",
"status": "active"
}
],
"date": "2026-02-25T13:13:43Z",
"description": "This is a Provider Selection Regime\u003cbr/\u003e(PSR) intention to award notice. The\u003cbr/\u003eawarding of this contract is subject to\u003cbr/\u003ethe Health Care Services (Provider\u003cbr/\u003eSelection Regime) Regulations 2023.\u003cbr/\u003eFor the avoidance of doubt, the\u003cbr/\u003eprovisions of the Public Contracts\u003cbr/\u003eRegulations 2015 do not apply to this\u003cbr/\u003eaward. The standstill period begins on\u003cbr/\u003ethe day after the publication of this\u003cbr/\u003enotice. Representations by providers\u003cbr/\u003emust be made to decision makers by\u003cbr/\u003e09/03/2026. This contract has not yet\u003cbr/\u003eformally been awarded; this notice\u003cbr/\u003eserves as an intention to award under\u003cbr/\u003ethe PSR.\u2019\u003cbr/\u003e\u003cbr/\u003eAward decision-makers;\u003cbr/\u003eAfruj Ruf\u003cbr/\u003eLucy Jenkinson\u003cbr/\u003e\u201cBased on the Authorities assessment\u003cbr/\u003eand PSR decision making process\u003cbr/\u003e(taking into account key criteria; quality,\u003cbr/\u003evalue, integration, inequalities and\u003cbr/\u003eaccess), ILS LLP intends to award a\u003cbr/\u003econtract to an existing provider\u003cbr/\u003efollowing Direct Award Process C under\u003cbr/\u003ethe Provider Selection Regime (PSR).\u003cbr/\u003e\u003cbr/\u003eThe authority is proposing a new\u003cbr/\u003econtract to replace the existing contract\u003cbr/\u003eat the end of its term and the proposed\u003cbr/\u003econtracting arrangements are not\u003cbr/\u003echanging considerably.\u003cbr/\u003e\u003cbr/\u003eILS LLP is of the view that the existing\u003cbr/\u003eprovider is satisfying the contract to a\u003cbr/\u003esufficient standard and will likely satisfy\u003cbr/\u003ethe proposed contract to a sufficient\u003cbr/\u003estandard.\u003cbr/\u003e\u003cbr/\u003eDirect Award Processes A (only one\u003cbr/\u003eprovider can provide the services) and\u003cbr/\u003eB (unrestricted patient choice) do not\u003cbr/\u003eapply and a competitive process is\u003cbr/\u003eunlikely to add value for patients,\u003cbr/\u003etaxpayers, or the population.\u003cbr/\u003e\u003cbr/\u003eThe publication of this notice marks the\u003cbr/\u003estart of the standstill period.\u003cbr/\u003eRepresentations by providers must be\u003cbr/\u003emade to decision makers by midnight\u003cbr/\u003eon 09/03/2026 (End of standstill Period) (8 working days from\u003cbr/\u003epublication) via email to:\u003cbr/\u003eXander.mcconville@nhs.net\u003cbr/\u003e\u003cbr/\u003eThis contract has not yet formally been\u003cbr/\u003eawarded; this notice serves as an\u003cbr/\u003eintention to award under the PSR. The\u003cbr/\u003econtract will not be awarded until the\u003cbr/\u003eperiod has ended and any\u003cbr/\u003erepresentations have been considered.\u003cbr/\u003e\u003cbr/\u003eNo conflicts of interest were identified\u003cbr/\u003eduring the procurement process.\u003cbr/\u003e\u003cbr/\u003eNo subcontracting is expected.",
"id": "016885-2026",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-065c04",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "Keighley",
"postalCode": "BD20 6TD",
"region": "UKE41",
"streetAddress": "Airedale General Hospital, Skipton Road, Steeton"
},
"contactPoint": {
"email": "saranne.tate@nhs.net",
"name": "Saranne Tate",
"telephone": "+44 1535294510"
},
"details": {
"buyerProfile": "https://www.airdale-trust.nhs.uk",
"classifications": [
{
"description": "Regional or local authority",
"id": "REGIONAL_AUTHORITY",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "https://www.airdale-trust.nhs.uk"
},
"id": "GB-FTS-172659",
"identifier": {
"id": "OC404345",
"legalName": "Integrated Laboratory Solutions LLP"
},
"name": "Integrated Laboratory Solutions LLP",
"roles": [
"buyer"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "London",
"postalCode": "W1G 0PU",
"region": "UK",
"streetAddress": "2 Cavendish Square, London, W1G 0PU"
},
"details": {
"scale": "large",
"url": "http://www.hcahealthcare.co.uk"
},
"id": "GB-FTS-175395",
"identifier": {
"id": "03020522",
"legalName": "HCA International Limited"
},
"name": "HCA International Limited",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Keighley",
"postalCode": "BD20 6TD",
"streetAddress": "Airedale General Hospital, Skipton Road, Steeton"
},
"contactPoint": {
"email": "saranne.tate@nhs.net"
},
"details": {
"url": "https://www.airdale-trust.nhs.uk"
},
"id": "GB-FTS-172661",
"identifier": {
"legalName": "Integrated Laboratory Solutions LLP"
},
"name": "Integrated Laboratory Solutions LLP",
"roles": [
"reviewBody"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"classification": {
"description": "Pathology services",
"id": "85111800",
"scheme": "CPV"
},
"description": "* PSR DIRECT AWARD C INTENT TO AWARD NOTICE **- CALL OFF CONTRACT FOR CHEMISTRY TESTING INTENT TO AWARD TO AN EXISITING SUPPLIER.\u003cbr/\u003eVALUE OF THE CONTRACT \u00a360,000\u003cbr/\u003eTO BE FOR THE PERIOD 01/04/2026 TO 31/03/2027.\u003cbr/\u003ePROVISION OF REFERRAL SERVICES FOR CHEMISTRY DIAGNOSTIC TESTS, TO BE DELIVERED AS AND WHEN REQUIRED BY THE CONTRACTING AUTHORITY. THE CONTRACT VALUE IS ESTIMATED AND WILL VARY BASED ON ACTIVITY LEVELS. THE INITIAL CONTRACT TERM WILL RUN FROM 01/04/2026 TO 31/03/2027, WITH THE OPTION FOR THE AUTHORITY TO EXTEND FOR UP TO TWO ADDITIONAL PERIODS OF 12 MONTHS EACH.",
"id": "C380568",
"items": [
{
"deliveryAddresses": [
{
"region": "UK"
}
],
"deliveryLocation": {
"description": "Harrogate District Hospital, 17 Wetherby Road"
},
"id": "1",
"relatedLot": "1"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"description": "100",
"name": "the existing provider is satisfying the original contract and will likely satisfy the proposed contract to a sufficient standard",
"type": "cost"
}
]
},
"description": "* PSR DIRECT AWARD C INTENT TO AWARD NOTICE **- CALL OFF CONTRACT FOR CHEMISTRY TESTING INTENT TO AWARD TO AN EXISITING SUPPLIER.\u003cbr/\u003eVALUE OF THE CONTRACT \u00a360,000\u003cbr/\u003eTO BE FOR THE PERIOD 01/04/2026 TO 31/03/2027.\u003cbr/\u003ePROVISION OF REFERRAL SERVICES FOR CHEMISTRY DIAGNOSTIC TESTS, TO BE DELIVERED AS AND WHEN REQUIRED BY THE CONTRACTING AUTHORITY. THE CONTRACT VALUE IS ESTIMATED AND WILL VARY BASED ON ACTIVITY LEVELS. THE INITIAL CONTRACT TERM WILL RUN FROM 01/04/2026 TO 31/03/2027, WITH THE OPTION FOR THE AUTHORITY TO EXTEND FOR UP TO TWO ADDITIONAL PERIODS OF 12 MONTHS EACH.\u003cbr/\u003e\u003cbr/\u003eTHIS CONTRACT HAS NOT YET\u003cbr/\u003eFORMALLY BEEN AWARDED; THIS\u003cbr/\u003eNOTICE SERVES AS AN INTENTION\u003cbr/\u003eTO AWARD UNDER THE PSR. THE\u003cbr/\u003eCONTRACT WILL NOT BE AWARDED\u003cbr/\u003eUNTIL THE PERIOD HAS ENDED\u003cbr/\u003eAND ANY REPRESENTATIONS HAVE\u003cbr/\u003eBEEN CONSIDERED.\u003cbr/\u003e\u003cbr/\u003eNO CONFLICTS OF INTEREST WERE\u003cbr/\u003eIDENTIFIED DURING THE\u003cbr/\u003ePROCUREMENT PROCESS.\u003cbr/\u003e\u003cbr/\u003eNO SUBCONTRACTING IS\u003cbr/\u003eEXPECTED. Additional information: * PSR DIRECT AWARD C INTENT TO AWARD NOTICE **- CALL OFF CONTRACT FOR CHEMISTRY TESTING INTENT TO AWARD TO AN EXISITING SUPPLIER.\u003cbr/\u003eVALUE OF THE CONTRACT \u00a360,000\u003cbr/\u003eTO BE FOR THE PERIOD 01/04/2026 TO 31/03/2027.\u003cbr/\u003ePROVISION OF REFERRAL SERVICES FOR CHEMISTRY DIAGNOSTIC TESTS, TO BE DELIVERED AS AND WHEN REQUIRED BY THE CONTRACTING AUTHORITY. THE CONTRACT VALUE IS ESTIMATED AND WILL VARY BASED ON ACTIVITY LEVELS. THE INITIAL CONTRACT TERM WILL RUN FROM 01/04/2026 TO 31/03/2027, WITH THE OPTION FOR THE AUTHORITY TO EXTEND FOR UP TO TWO ADDITIONAL PERIODS OF 12 MONTHS EACH.\u003cbr/\u003e\u003cbr/\u003eTHIS CONTRACT HAS NOT YET\u003cbr/\u003eFORMALLY BEEN AWARDED; THIS\u003cbr/\u003eNOTICE SERVES AS AN INTENTION\u003cbr/\u003eTO AWARD UNDER THE PSR. THE\u003cbr/\u003eCONTRACT WILL NOT BE AWARDED\u003cbr/\u003eUNTIL THE PERIOD HAS ENDED\u003cbr/\u003eAND ANY REPRESENTATIONS HAVE\u003cbr/\u003eBEEN CONSIDERED.\u003cbr/\u003e\u003cbr/\u003eNO CONFLICTS OF INTEREST WERE\u003cbr/\u003eIDENTIFIED DURING THE\u003cbr/\u003ePROCUREMENT PROCESS.\u003cbr/\u003e\u003cbr/\u003eNO SUBCONTRACTING IS\u003cbr/\u003eEXPECTED",
"hasOptions": false,
"id": "1",
"status": "cancelled"
}
],
"mainProcurementCategory": "services",
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "\u2018This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by 09/03/2026. This contract has not yet formally been awarded; this notice serves as an intention to award under the PSR\u0027.",
"procurementMethodRationaleClassifications": [
{
"description": "The procurement falls outside the scope of application of the directive",
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
}
],
"status": "complete",
"title": "CALL OFF ORDER FOR SPECIALIST RESPIRATORY TESTING OF HIGH_RISK MICROBIOLOGY TESTS"
}
}